You have 9 free searches left this month | for more free features.

Fimasartan

Showing 1 - 25 of 76

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Essential Hypertension Trial in Bucheon-si (Fimasartan + Indapamide, Fimasartan + Indapamide )

Recruiting
  • Essential Hypertension
  • Fimasartan + Indapamide
  • Fimasartan + Indapamide placebo
  • Bucheon-si, Kyunggi-do, Korea, Republic of
    The Catholic University of Korea, Bucheon St.Mary's Hospital
May 18, 2023

A Combination Drug Including Fimasartan and Statins in

Completed
  • Hypertension and Dyslipidemia
  • Combination drug containing fimasartan and statins
  • Gwangju, Jebong-ro, Jangseong-eup, Jangseong-gun, Korea, Republic of
    Chonnam National University Hospital
Nov 15, 2022

Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ

Recruiting
  • Hypertension,Essential
    • Seoul, Korea, Republic of
      Seoul National University Bundang Hospital
    Jul 7, 2022

    Essential Hypertension, Primary Hypercholesterolemia Trial in Seoul (Fimasartan, Ezetimibe/Atorvastatin, Fimasartan Placebo)

    Not yet recruiting
    • Essential Hypertension
    • Primary Hypercholesterolemia
    • Fimasartan
    • +3 more
    • Seoul, Korea, Republic of
      Severance Hospital
    Jun 26, 2023

    Hypertension, Atherosclerosis, Diabetes, Type 2 Trial in Seongnam (Fimasartan)

    Recruiting
    • Hypertension
    • +3 more
    • Fimasartan
    • Seongnam, Gyeonggi, Korea, Republic of
      Seoul National University Bundang Hospital
    Dec 27, 2021

    Essential Hypertension Trial in Seoul (Fimasartan/Amlodipine)

    Completed
    • Essential Hypertension
    • Seoul, Korea, Republic of
      Boryung Pharmaceutical Co., Ltd
    Jul 28, 2021

    Renoprotective Effect of Fimasartan in DKD and Proteinuria

    Recruiting
    • Diabetic Kidney Disease
    • +2 more
      • Seoul, Korea, Republic of
        Severance hospital, Yonsei University Health System
      Oct 7, 2021

      Hypertension Trial in Gyeonggi-do (BR1015-1, BR1015-2, BR1015-1 + BR1015-2)

      Completed
      • Hypertension
      • Gyeonggi-do, Seongnam-si, Korea, Republic of
        CHA Bundang Medical Center, CHA University
      Nov 18, 2021

      Hypertension, Hypercholesterinemia Trial in Gyeonggi-do (BR1017-1, BR1017-2)

      Recruiting
      • Hypertension
      • Hypercholesterinemia
      • Gyeonggi-do, Seongnam-si, Korea, Republic of
        CHA Bundang Medical Center, CHA University
      May 11, 2022

      FimasaRtan-basEd BP Targets After Drug SwitcHing

      Completed
      • Essential Hypertension
        • Suwon, Korea, Republic of
          Ajou University Hospital
        Dec 22, 2020

        The Elderly (= 70 Years) With Essential Hypertension Trial in Seoul (Fimasartan or Fimasartan/Hydrochlorothiazide, Perindopril

        Completed
        • The Elderly (≥ 70 Years) With Essential Hypertension
        • Fimasartan or Fimasartan/Hydrochlorothiazide
        • Perindopril or Perindopril/Indapamide
        • Seoul, Korea, Republic of
          Seoul National University Bundang
        Mar 19, 2020

        Hypertension, Diabetes Trial in Seoul (Treatment A (Fimasartan, Linagliptin), Treatment B (Fimasartan/Linagliptin))

        Completed
        • Hypertension
        • Diabetes
        • Treatment A (Fimasartan, Linagliptin)
        • Treatment B (Fimasartan/Linagliptin)
        • Seoul, Dahak-ro, Korea, Republic of
          Seoul National University Hospital
        Feb 3, 2020

        Essential Hypertension, Dyslipidemia Trial in Seoul (Fimasartan 120mg, Atorvastatin 40mg, Placebo for Fimasartan 120mg)

        Completed
        • Essential Hypertension, Dyslipidemia
        • Fimasartan 120mg
        • +3 more
        • Seoul, Korea, Republic of
          Severance Hospital
        Nov 4, 2019

        Essential Hypertension, Dyslipidemia Trial in Seoul (Fimasartan/Amlodipine, Rosuvastatin, Fimasartan/Amlodipine, Fimasartan,

        Completed
        • Essential Hypertension
        • Dyslipidemia
        • Fimasartan/Amlodipine, Rosuvastatin
        • +2 more
        • Seoul, Korea, Republic of
          Samsung Medical Center
        Jun 7, 2019

        Fimasartan Blood Pressure Lowering After Acute Stroke

        Completed
        • Hypertension
        • +2 more
          • Ansan, Korea, Republic of
          • +26 more
          Nov 1, 2019

          Essential Hypertension Trial in Seoul

          Completed
          • Essential Hypertension
            • Seoul, Korea, Republic of
              Yoon Jun Kim
            Feb 10, 2019

            Hypertension Trial (Fimasartan, Rosuvastatin, Fimasartan + Rosuvastatin)

            Completed
            • Hypertension
            • Fimasartan
            • +2 more
            • (no location specified)
            Feb 5, 2018

            Arterial Hypertension Trial in Russian Federation (Fimasartan, Losartan)

            Completed
            • Arterial Hypertension
            • Moscow, Russian Federation
            • +12 more
            Feb 5, 2019

            Cardiovascular Diseases, Heart Failure With Reduced Ejection Fraction Trial in Ostrava (Nebivolol, Valsartan and Sacubitril,

            Not yet recruiting
            • Cardiovascular Diseases
            • Heart Failure With Reduced Ejection Fraction
            • Ostrava, Czech Republic, Czechia
              University Hospital Ostrava
            Sep 6, 2023

            Pharmacokinetics Trial in Seoul (Treatment T, Treatment R)

            Completed
            • Pharmacokinetics
            • Treatment T
            • Treatment R
            • Seoul, Jongno-gu, Korea, Republic of
              Seoul National University Hospital
            Jan 8, 2019

            Drug-Drug Interaction Trial in Busan (Fimasartan/Amlodipine combination drug, Hydrochlorothiazide)

            Completed
            • Drug-Drug Interaction
            • Fimasartan/Amlodipine combination drug, Hydrochlorothiazide
            • Busan, Korea, Republic of
              Inje University Busan Paik Hospital
            Aug 8, 2018

            Coronary Artery Disease Trial in Gwangju, Seoul, Ulsan (Fimasartan, Placebo)

            Terminated
            • Coronary Artery Disease
            • Fimasartan
            • Placebo
            • Gwangju, Korea, Republic of
            • +2 more
            Jun 19, 2018

            Essential Hypertension Trial (Fimasartan 60 mg group, Fimasartan 120 mg group, Reference (Valsartan 80 mg) group)

            Completed
            • Essential Hypertension
            • Fimasartan 60 mg group
            • +2 more
            • (no location specified)
            Feb 19, 2018

            Hypertension Trial (Fimasartan/Amlodipine, Fimasartan + Amlodipine)

            Completed
            • Hypertension
            • (no location specified)
            Jan 7, 2018

            Hypertension Trial (Fimasartan, Losartan (Control))

            Completed
            • Hypertension
            • Fimasartan
            • Losartan (Control)
            • (no location specified)
            Mar 15, 2018